000 | 01094 a2200301 4500 | ||
---|---|---|---|
005 | 20250515093906.0 | ||
264 | 0 | _c20080123 | |
008 | 200801s 0 0 eng d | ||
022 | _a1468-201X | ||
024 | 7 |
_a10.1136/hrt.2007.132894 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChung, H | |
245 | 0 | 0 |
_aAlteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance. _h[electronic resource] |
260 |
_bHeart (British Cardiac Society) _cDec 2007 |
||
300 |
_a1616-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 |
_aStroke _xdrug therapy |
650 | 0 | 4 | _aTechnology Assessment, Biomedical |
650 | 0 | 4 |
_aTissue Plasminogen Activator _xtherapeutic use |
700 | 1 | _aRefoios Camejo, R | |
700 | 1 | _aCamejo, R R | |
700 | 1 | _aBarnett, D | |
773 | 0 |
_tHeart (British Cardiac Society) _gvol. 93 _gno. 12 _gp. 1616-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/hrt.2007.132894 _zAvailable from publisher's website |
999 |
_c17520720 _d17520720 |